Precision medicine (PM) is significantly changing the way therapies are being developed, benefiting patients, the pharmaceutical industry, and the society. The Malaysian Association for Cancer Research (MACR), which was established in 2017, quickly saw the importance of PM and aspired to create a global platform for sharing of recent research findings of this field in relation to drug discoveries and translational medicine.

MIHAS is a robust marketplace for both international and local players to seize opportunities beyond Halal food including Halal pharmaceutical, medical devices, finance, modest fashion, personal care and cosmetics, green technologies, and even Muslim-friendly tourism.